Correction: Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients Authors: Khusbhoo A. Gandhi, Rohan Chaubal, Elizabeth Talker, Jaya Chitra Aadhi, Shwetali Pandey, Rushikesh Mukhare, Anushree Kadam, Ankita Singh, Mamta Gurav, Pallavi Parab, Yogesh Kembhavi, Rahul Thorat, Anbarasan Sekar, Seema Gulia, Kunal Gala, Nitin Shetty, Shalaka Joshi, Suyash Kulkarni, Tanuja Shet, Sudeep Gupta Published: 2026 Correction to: Scientific Reports https://doi.org/10.1038/s41598-025-22361-z, published online 04 November 2025 The original version of this Article contained an error in Figure 5, where one image corresponding to the G1 mice was inadvertently mislabelled as G0 during microscopy image acquisition and subsequent file organization. This mislabelling resulted in the incorrect assignment of a G1-estrogen receptor (G1-ER) image as a G0-ER image. The original Figure 5 and accompanying legend appear below. The original Article has been corrected.Fig. 5Histopathological and immunohistochemical characterization of the patient tumor (P156R) and corresponding PDX. Hematoxylin and eosin (H&E) staining of the PDX demonstrated that the histopathological architecture of developed PDXs are consistent with the resected patient tumor. Immunohistochemical analysis showed strong nuclear estrogen receptor (ER)-positivity in the patient tumor and PDX (Allred score: 8/8). Progesterone receptor (PR) staining was 10% (weak positive) in patient tumor and negative in the PDX (Allred score: 2/8). HER2 staining was negative in the patient tumor and PDX. Images were captured at 200× magnification. ER, estrogen receptor; PR, progesterone receptor. Histopathological and immunohistochemical characterization of the patient tumor (P156R) and corresponding PDX. Hematoxylin and eosin (H&E) staining of the PDX demonstrated that the histopathological architecture of developed PDXs are consistent with the resected patient tumor. Immunohistochemical analysis showed strong nuclear estrogen receptor (ER)-positivity in the patient tumor and PDX (Allred score: 8/8). Progesterone receptor (PR) staining was 10% (weak positive) in patient tumor and negative in the PDX (Allred score: 2/8). HER2 staining was negative in the patient tumor and PDX. Images were captured at 200× magnification. ER, estrogen receptor; PR, progesterone receptor.